{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:44:26Z","timestamp":1793054666935,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2021A1515110266"],"award-info":[{"award-number":["2021A1515110266"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2019A1515011098"],"award-info":[{"award-number":["2019A1515011098"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the China Postdoctoral Science special Foundation funded project","award":["2021TQ0386"],"award-info":[{"award-number":["2021TQ0386"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81900329"],"award-info":[{"award-number":["81900329"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81870195"],"award-info":[{"award-number":["81870195"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515011668"],"award-info":[{"award-number":["2021A1515011668"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The triglyceride-glucose (TyG) index is a reliable surrogate marker of insulin resistance (IR). However, whether the TyG index has prognostic value in patients with moderate to severe aortic stenosis (AS) remains unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study enrolled 317 patients with moderate to severe AS at the First Affiliated Hospital of Sun Yat-Sen University. The patients were grouped according to the cut-off value of the TyG index. Cox regression with Firth\u2019s penalized maximum likelihood method and restricted cubic splines regression were conducted to assess the association between the TyG index and all-cause mortality. The added value of the TyG index included in the traditional risk factors model for outcome prediction was also analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among 317 patients (mean age 67.70 years, 62.8% male), there was 84 all-cause mortality during a median 38.07 months follow-up. After fully adjusting for confounders, a per-unit increase in the TyG index was associated with a 62% higher all-cause mortality risk (HR 1.622, 95% CI 1.086\u20132.416, <jats:italic>p<\/jats:italic>\u2009=\u20090.018). The restricted cubic splines regression model revealed a linear association between the TyG index and the risk of all-cause mortality (<jats:italic>p<\/jats:italic> for nonlinearity\u2009=\u20090.632). The addition of the TyG index in the basic risk model has an incremental effect on the prediction of mortality [C-statistic change from 0.755 to 0.768; continuous net reclassification improvement (95% CI): 0.299 (0.051\u20130.546), <jats:italic>p<\/jats:italic>\u2009=\u20090.017; integrated discrimination improvement: 0.017 (0.001\u20130.033), <jats:italic>p<\/jats:italic>\u2009=\u20090.044].<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Higher IR assessed by the TyG index was associated with a higher risk of all-cause mortality in patients with moderate and severe AS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-023-01975-5","type":"journal-article","created":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T17:01:33Z","timestamp":1693674093000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Association between the insulin resistance and all-cause mortality in patients with moderate and severe aortic stenosis: a retrospective cohort study"],"prefix":"10.1186","volume":"22","author":[{"given":"Rihua","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoguang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaozhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiquan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxue","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,2]]},"reference":[{"issue":"4","key":"1975_CR1","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1161\/ATVBAHA.119.313067","volume":"40","author":"PR Goody","year":"2020","unstructured":"Goody PR, Hosen MR, Christmann D, Niepmann ST, Zietzer A, Adam M, Bonner F, Zimmer S, Nickenig G, Jansen F. Aortic valve stenosis: from Basic Mechanisms to Novel therapeutic targets. Arterioscler Thromb Vasc Biol. 2020;40(4):885\u2013900.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"1975_CR2","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/s41569-021-00570-z","volume":"18","author":"S Coffey","year":"2021","unstructured":"Coffey S, Roberts-Thomson R, Brown A, Carapetis J, Chen M, Enriquez-Sarano M, Zuhlke L, Prendergast BD. Global epidemiology of valvular heart disease. Nat Rev Cardiol. 2021;18(12):853\u201364.","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"1975_CR3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R, et al. 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561\u2013632.","journal-title":"Eur Heart J"},{"issue":"5","key":"1975_CR4","first-page":"e72","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, et al. 2020 ACC\/AHA Guideline for the management of patients with Valvular Heart Disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e72\u2013e227.","journal-title":"Circulation"},{"issue":"5","key":"1975_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrendo.2014.29","volume":"10","author":"M Laakso","year":"2014","unstructured":"Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol. 2014;10(5):293\u2013302.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"1975_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jacc.2018.04.064","volume":"72","author":"E Salaun","year":"2018","unstructured":"Salaun E, Mahjoub H, Dahou A, Mathieu P, Larose E, Despres JP, Rodes-Cabau J, Arsenault BJ, Puri R, Clavel MA, et al. Hemodynamic deterioration of surgically implanted Bioprosthetic aortic valves. J Am Coll Cardiol. 2018;72(3):241\u201351.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1975_CR7","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1016\/j.jacc.2005.12.073","volume":"47","author":"M Briand","year":"2006","unstructured":"Briand M, Lemieux I, Dumesnil JG, Mathieu P, Cartier A, Despres JP, Arsenault M, Couet J, Pibarot P. Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. J Am Coll Cardiol. 2006;47(11):2229\u201336.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1975_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12933-019-0836-y","volume":"18","author":"E Ram","year":"2019","unstructured":"Ram E, Kogan A, Levin S, Fisman EZ, Tenenbaum A, Raanani E, Sternik L. Type 2 diabetes mellitus increases long-term mortality risk after isolated surgical aortic valve replacement. Cardiovasc Diabetol. 2019;18(1):31.","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"1975_CR9","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.3390\/ijms22126212","volume":"22","author":"L Mourino-Alvarez","year":"2021","unstructured":"Mourino-Alvarez L, Corbacho-Alonso N, Sastre-Oliva T, Corros-Vicente C, Solis J, Tejerina T, Padial LR, Barderas MG. Diabetes mellitus and its implications in aortic stenosis patients. Int J Mol Sci. 2021;22(12):6212.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1975_CR10","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/oby.23503","volume":"30","author":"A Gastaldelli","year":"2022","unstructured":"Gastaldelli A. Measuring and estimating insulin resistance in clinical and research settings. Obes (Silver Spring). 2022;30(8):1549\u201363.","journal-title":"Obes (Silver Spring)"},{"issue":"7","key":"1975_CR11","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mendia LE, Gonzalez-Ortiz M, Martinez-Abundis E, Ramos-Zavala MG, Hernandez-Gonzalez SO, Jacques-Camarena O, Rodriguez-Moran M. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347\u201351.","journal-title":"J Clin Endocrinol Metab"},{"key":"1975_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.trsl.2020.08.003","volume":"228","author":"B Park","year":"2021","unstructured":"Park B, Lee HS, Lee YJ. Triglyceride glucose (TyG) index as a predictor of incident type 2 diabetes among nonobese adults: a 12-year longitudinal study of the korean genome and epidemiology study cohort. Transl Res. 2021;228:42\u201351.","journal-title":"Transl Res"},{"issue":"1","key":"1975_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12933-022-01732-0","volume":"22","author":"Y Yang","year":"2023","unstructured":"Yang Y, Huang X, Wang Y, Leng L, Xu J, Feng L, Jiang S, Wang J, Yang Y, Pan G, et al. The impact of triglyceride-glucose index on ischemic stroke: a systematic review and meta-analysis. Cardiovasc Diabetol. 2023;22(1):2.","journal-title":"Cardiovasc Diabetol"},{"key":"1975_CR14","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1093\/eurjpc\/zwac058","volume":"29","author":"R Huang","year":"2022","unstructured":"Huang R, Lin Y, Ye X, Zhong X, Xie P, Li M, Zhuang X, Liao X. Triglyceride-glucose index in the development of heart failure and left ventricular dysfunction: analysis of the ARIC study. Eur J Prev Cardiol. 2022;29:1531\u201341.","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"1975_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12933-023-01795-7","volume":"22","author":"Q Gao","year":"2023","unstructured":"Gao Q, Lin Y, Xu R, Luo F, Chen R, Li P, Zhang Y, Liu J, Deng Z, Li Y, et al. Positive association of triglyceride-glucose index with new-onset hypertension among adults: a national cohort study in China. Cardiovasc Diabetol. 2023;22(1):58.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1975_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12933-023-01737-3","volume":"22","author":"R Zhang","year":"2023","unstructured":"Zhang R, Shi S, Chen W, Wang Y, Lin X, Zhao Y, Liao L, Guo Q, Zhang X, Li W, et al. Independent effects of the triglyceride-glucose index on all-cause mortality in critically ill patients with coronary heart disease: analysis of the MIMIC-III database. Cardiovasc Diabetol. 2023;22(1):10.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1975_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12933-022-01472-1","volume":"21","author":"M Miao","year":"2022","unstructured":"Miao M, Zhou G, Bao A, Sun Y, Du H, Song L, Cao Y, You S, Zhong C. Triglyceride-glucose index and common carotid artery intima-media thickness in patients with ischemic stroke. Cardiovasc Diabetol. 2022;21(1):43.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"1975_CR18","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.echo.2017.02.009","volume":"30","author":"H Baumgartner","year":"2017","unstructured":"Baumgartner H, Hung J, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, Lancellotti P, LeFevre M, Miller F Jr, Otto CM. Recommendations on the echocardiographic Assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2017;30(4):372\u201392.","journal-title":"J Am Soc Echocardiogr"},{"issue":"12","key":"1975_CR19","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","volume":"17","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, et al. Recommendations for the evaluation of left ventricular diastolic function by Echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(12):1321\u201360.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"1975_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1\u201339e14.","journal-title":"J Am Soc Echocardiogr"},{"key":"1975_CR21","doi-asserted-by":"publisher","first-page":"m2297","DOI":"10.1136\/bmj.m2297","volume":"370","author":"X Cai","year":"2020","unstructured":"Cai X, Zhang Y, Li M, Wu JH, Mai L, Li J, Yang Y, Hu Y, Huang Y. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ. 2020;370:m2297.","journal-title":"BMJ"},{"issue":"7546","key":"1975_CR22","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1136\/bmj.38766.624097.1F","volume":"332","author":"J Sundstrom","year":"2006","unstructured":"Sundstrom J, Riserus U, Byberg L, Zethelius B, Lithell H, Lind L. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. BMJ. 2006;332(7546):878\u201382.","journal-title":"BMJ"},{"issue":"1","key":"1975_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12933-022-01593-7","volume":"21","author":"X Xu","year":"2022","unstructured":"Xu X, Huang R, Lin Y, Guo Y, Xiong Z, Zhong X, Ye X, Li M, Zhuang X, Liao X. High triglyceride-glucose index in young adulthood is associated with incident cardiovascular disease and mortality in later life: insight from the CARDIA study. Cardiovasc Diabetol. 2022;21(1):155.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1975_CR24","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s12967-022-03678-z","volume":"20","author":"Y Yu","year":"2022","unstructured":"Yu Y, Gu M, Huang H, Cheng S, Deng Y, Cai C, Chen X, Niu H, Ning X, Hua W. Combined association of triglyceride-glucose index and systolic blood pressure with all-cause and cardiovascular mortality among the general population. J Transl Med. 2022;20(1):478.","journal-title":"J Transl Med"},{"issue":"1","key":"1975_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12933-019-0957-3","volume":"18","author":"E Luo","year":"2019","unstructured":"Luo E, Wang D, Yan G, Qiao Y, Liu B, Hou J, Tang C. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention. Cardiovasc Diabetol. 2019;18(1):150.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1975_CR26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12933-023-01843-2","volume":"22","author":"Z Ye","year":"2023","unstructured":"Ye Z, An S, Gao Y, Xie E, Zhao X, Guo Z, Li Y, Shen N, Zheng J. Association between the triglyceride glucose index and in-hospital and 1-year mortality in patients with chronic kidney disease and coronary artery disease in the intensive care unit. Cardiovasc Diabetol. 2023;22(1):110.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1975_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12933-020-01006-7","volume":"19","author":"X Ma","year":"2020","unstructured":"Ma X, Dong L, Shao Q, Cheng Y, Lv S, Sun Y, Shen H, Wang Z, Zhou Y, Liu X. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):31.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1975_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12933-021-01443-y","volume":"21","author":"Y Jiao","year":"2022","unstructured":"Jiao Y, Su Y, Shen J, Hou X, Li Y, Wang J, Liu B, Qiu D, Sun Z, Chen Y, et al. Evaluation of the long-term prognostic ability of triglyceride-glucose index for elderly acute coronary syndrome patients: a cohort study. Cardiovasc Diabetol. 2022;21(1):3.","journal-title":"Cardiovasc Diabetol"},{"issue":"22","key":"1975_CR29","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1136\/heartjnl-2022-320897","volume":"108","author":"A Coisne","year":"2022","unstructured":"Coisne A, Montaigne D, Ninni S, Lamblin N, Lemesle G, Delsart P, Filiot A, Andrey P, Balaye P, Butruille L, et al. Diabetes mellitus and cardiovascular mortality across the spectrum of aortic stenosis. Heart. 2022;108(22):1815\u201321.","journal-title":"Heart"},{"issue":"1","key":"1975_CR30","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","volume":"17","author":"V Ormazabal","year":"2018","unstructured":"Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuniga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1975_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","volume":"21","author":"LC Tao","year":"2022","unstructured":"Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1975_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1001\/jama.2015.7008","volume":"314","author":"E Di Angelantonio","year":"2015","unstructured":"Di Angelantonio E, Kaptoge S, Wormser D, Willeit P, Butterworth AS, Bansal N, O\u2019Keeffe LM, Gao P, Wood AM, Burgess S, et al. Association of Cardiometabolic Multimorbidity with Mortality. JAMA. 2015;314(1):52\u201360.","journal-title":"JAMA"},{"issue":"1","key":"1975_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-019-0982-2","volume":"19","author":"J Alizargar","year":"2020","unstructured":"Alizargar J, Bai CH, Hsieh NC, Wu SV. Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients. Cardiovasc Diabetol. 2020;19(1):8.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"1975_CR34","doi-asserted-by":"publisher","first-page":"e028985","DOI":"10.1161\/JAHA.122.028985","volume":"12","author":"Z Ke","year":"2023","unstructured":"Ke Z, Huang R, Xu X, Liu W, Wang S, Zhang X, Guo Y, Zhuang X, Zhen L. Long-term high level of insulin resistance is Associated with an increased prevalence of coronary artery calcification: the CARDIA Study. J Am Heart Assoc. 2023;12(11):e028985.","journal-title":"J Am Heart Assoc"},{"issue":"13","key":"1975_CR35","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1001\/jama.299.13.1561","volume":"299","author":"SE Nissen","year":"2008","unstructured":"Nissen SE, Nicholls SJ, Wolski K, Nesto R, Kupfer S, Perez A, Jure H, De Larochelliere R, Staniloae CS, Mavromatis K, et al. Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. JAMA. 2008;299(13):1561\u201373.","journal-title":"JAMA"},{"issue":"14","key":"1975_CR36","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJMoa1506930","volume":"374","author":"WN Kernan","year":"2016","unstructured":"Kernan WN, Viscoli CM, Furie KL, Young LH, Inzucchi SE, Gorman M, Guarino PD, Lovejoy AM, Peduzzi PN, Conwit R, et al. Pioglitazone after ischemic stroke or transient ischemic attack. N Engl J Med. 2016;374(14):1321\u201331.","journal-title":"N Engl J Med"},{"issue":"6","key":"1975_CR37","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.hjc.2018.11.008","volume":"60","author":"E Andrikou","year":"2019","unstructured":"Andrikou E, Tsioufis C, Andrikou I, Leontsinis I, Tousoulis D, Papanas N. GLP-1 receptor agonists and cardiovascular outcome trials: an update. Hellenic J Cardiol. 2019;60(6):347\u201351.","journal-title":"Hellenic J Cardiol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01975-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-01975-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01975-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T13:30:24Z","timestamp":1700573424000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-01975-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,2]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1975"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-01975-5","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,2]]},"assertion":[{"value":"14 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Review Committee of the First Affiliated Hospital of Sun Yat-Sen University. Patient follow-up was conducted via telephone contact, with verbal informed consent approved by the institutional ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"238"}}